{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:00:52Z","timestamp":1649210452678},"reference-count":13,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/mco.2015.695","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T12:29:21Z","timestamp":1449577761000},"page":"151-153","source":"Crossref","is-referenced-by-count":1,"title":["Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case report"],"prefix":"10.3892","volume":"4","author":[{"given":"YUKIE","family":"FUJITA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AYA","family":"NAKAYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINYA","family":"FUJITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAAKI","family":"HOTTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEAKI","family":"YOSHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIKO","family":"AZUMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAHISA","family":"NAKANISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUSHI","family":"SATAKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUYOSHI","family":"ISHII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOKI","family":"ITO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHOSAKU","family":"NOMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"key20180107145857_b1-mco-0-0-695","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"listed: T he World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Histopathology","volume":"50","author":"No","year":"2000","journal-title":"Pathol Int"},{"key":"key20180107145857_b2-mco-0-0-695","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1440-1827.2007.02207.x","article-title":"Distribution of malignant lymphoma in Japan, Analysis of 2260 cases, 2001-2006","volume":"58","author":"Aoki","year":"2008","journal-title":"Pathol Int"},{"key":"key20180107145857_b3-mco-0-0-695","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20180107145857_b4-mco-0-0-695","author":"Swerdlow","year":"2008","journal-title":"WHO Classification of Tumours of Haematolopoietic and Lymphoid Tissues"},{"key":"key20180107145857_b5-mco-0-0-695","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","article-title":"Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine","volume":"11","author":"Imai","year":"1999","journal-title":"Int Immunol"},{"key":"key20180107145857_b6-mco-0-0-695","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","article-title":"Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107145857_b7-mco-0-0-695","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107145857_b8-mco-0-0-695","first-page":"605","article-title":"Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression, Analysis of prognosis","volume":"25","author":"Ohshima","year":"2004","journal-title":"Int J Oncol"},{"key":"key20180107145857_b9-mco-0-0-695","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-08-1808","article-title":"Array comparative genomic hybridization analysis of PTCL-U reveals a distinct subgroup with genetic alterations similar to lymphoma-type adult T-cell leukemia\/lymphoma","volume":"15","author":"Nakagawa","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107145857_b10-mco-0-0-695","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1349-7006.2010.01767.x","article-title":"Immunopathogenesis of lymphoma: Focus on CCR4","volume":"102","author":"Ishida","year":"2011","journal-title":"Cancer Sci"},{"key":"key20180107145857_b11-mco-0-0-695","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-04-0371","article-title":"CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified","volume":"10","author":"Ishida","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107145857_b12-mco-0-0-695","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107145857_b13-mco-0-0-695","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2015.695\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T09:59:04Z","timestamp":1515319144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2015.695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,12,7]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/mco.2015.695"],"URL":"https:\/\/doi.org\/10.3892\/mco.2015.695","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}